Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CVAC NASDAQ:HTCR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVACCureVac$5.46$4.69$2.37▼$5.72$1.22B2.53781,168 shs830,036 shsHTCRHeartCore Enterprises$0.47+1.9%$0.54$0.39▼$3.38$10.35M1.89365,882 shs75,612 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVACCureVac0.00%+1.20%-1.97%+66.97%+67.48%HTCRHeartCore Enterprises0.00%+8.60%-6.34%-25.30%-39.24%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCVACCureVac4.752 of 5 stars4.15.00.04.92.50.01.3HTCRHeartCore Enterprises1.9168 of 5 stars0.05.02.50.02.21.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCVACCureVac 2.20Hold$6.8325.15% UpsideHTCRHeartCore Enterprises 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest HTCR and CVAC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/26/2025CVACCureVacUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Neutral$12.00 ➝ $5.506/13/2025CVACCureVacJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold$7.00 ➝ $5.006/12/2025CVACCureVacCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeMarket Perform6/12/2025CVACCureVacCitizens JmpSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/28/2025CVACCureVacJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$10.004/30/2025CVACCureVacUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$13.00 ➝ $12.00(Data available from 7/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCVACCureVac$579.18M2.11$0.87 per share6.25$3.36 per share1.63HTCRHeartCore Enterprises$28.95M0.36$0.74 per share0.63$0.17 per share2.76Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCVACCureVac$175.50M$0.925.93N/AN/A35.44%30.89%25.54%8/13/2025 (Estimated)HTCRHeartCore Enterprises-$1.48M-$0.14N/A2.93N/A-11.18%76.78%23.06%N/ALatest HTCR and CVAC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/22/2025Q1 2025CVACCureVac-$0.16-$0.24-$0.08-$0.24$4.27 million$0.94 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCVACCureVacN/AN/AN/AN/AN/AHTCRHeartCore Enterprises$0.024.26%N/AN/A N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCVACCureVac0.057.657.64HTCRHeartCore Enterprises2.010.910.91Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCVACCureVac17.26%HTCRHeartCore Enterprises1.71%Insider OwnershipCompanyInsider OwnershipCVACCureVacN/AHTCRHeartCore Enterprises64.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCVACCureVac880224.34 millionN/AOptionableHTCRHeartCore Enterprises4022.08 million7.90 millionNot OptionableHTCR and CVAC HeadlinesRecent News About These CompaniesCritical Comparison: HeartCore Enterprises (NASDAQ:HTCR) and Red Violet (NASDAQ:RDVT)July 10, 2025 | americanbankingnews.comHeartcore Enterprises Inc. (HTCR) Stock Price Today - WSJJuly 4, 2025 | wsj.comHeartCore Announces Strategic Financing to Support Software Business Growth Initiatives - MorningstarJuly 3, 2025 | morningstar.comMHeartCore Enterprises, Inc. Secures $27 Million Financing Agreement to Enhance M&A Strategy and Support Software Growth Initiatives - NasdaqJuly 3, 2025 | nasdaq.comHeartCore Signs 16th Go IPO ContractJuly 2, 2025 | globenewswire.comHeartCore Enterprises, Inc. Secures $27 Million Financing Agreement to Enhance M&A Strategy and Support Software Growth InitiativesJuly 1, 2025 | quiverquant.comQHeartCore Enterprises Secures $25M Equity Purchase AgreementJuly 1, 2025 | tipranks.comHeartCore Announces Strategic Financing to Support Software Business Growth InitiativesJuly 1, 2025 | globenewswire.comHeartCore Partners with Silver Egg Technology to Integrate New Recommendation Engine into its CMS PlatformJune 25, 2025 | globenewswire.comHeartCore Enterprises Secures 15th Go IPO Consulting WinJune 3, 2025 | tipranks.comHeartCore Enterprises, Inc. Signs Consulting Agreement with tmsuk Co. Ltd. for IPO ServicesJune 3, 2025 | quiverquant.comQHeartCore Signs 15th Go IPO ContractJune 3, 2025 | globenewswire.comHeartCore Enterprises Inc.: HeartCore Reports First Quarter 2025 Financial ResultsMay 15, 2025 | finanznachrichten.deHeartCore Enterprises, Inc. (HTCR) Reports Q1 Loss, Misses Revenue EstimatesMay 15, 2025 | zacks.comHeartCore Reports First Quarter 2025 Financial ResultsMay 15, 2025 | globenewswire.comHeartCore to Present at Sidoti Micro-Cap Virtual Conference on May 21, 2025 at 11:30 a.m. ETMay 7, 2025 | globenewswire.comHeartCore to Present in the Centri Capital Conference on April 22, 2025 at 9:30 a.m. ETApril 9, 2025 | globenewswire.comHeartCore to Present in the Centri Capital Conference on April 22, 2025 at 9:30 a.m. ETApril 9, 2025 | globenewswire.comHeartCore Enterprises enters partnership with NEC Solution InnovatorsApril 8, 2025 | markets.businessinsider.comHeartCore Announces Strategic Partnership with NEC Solution Innovators, Ltd. to Enhance CMS Implementation ProcessApril 7, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHTCR and CVAC Company DescriptionsCureVac NASDAQ:CVAC$5.46 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$5.44 -0.03 (-0.46%) As of 05:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202 which is in Phase 1 clinical trial for the treatment of rabies; and CVSQIV to treat multivalent seasonal influenza; Flu SV mRNA fot treating nucleotides, single antigen seasonal influenza. The company develops CV8102, which is in Phase 1 clinical trial for treating melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CVGBM for treating cancer. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.HeartCore Enterprises NASDAQ:HTCR$0.47 +0.01 (+1.91%) Closing price 04:00 PM EasternExtended Trading$0.47 +0.00 (+0.43%) As of 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.HeartCore Enterprises, Inc., a software development company, provides Software as a Service solutions to enterprise customers in Japan and internationally. Its customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. The company also operates a digital transformation business that offers customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises. In addition, it provides consulting services; and education, services, and support solutions. The company was founded in 2009 and is headquartered in Tokyo, Japan. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Insider Selling Hits Market Leaders—Should You Be Worried? MP Materials Stock Booms on New Government Positioning Tilray Shares Blazing: What's Behind the 55% Rally This Month? MarketBeat Week in Review – 07/07 - 07/11 How Texas Roadhouse Is Winning in a Changing Consumer Market Power Solutions International Poised for 75% Upside The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
